GURU.Markets stock price, segment price, and overall market index valuation
The company's share price XTNT
Xtant Medical produces biological implants for spinal surgery. Its stock price reflects its struggle for growth and profitability in the competitive medical technology market. The chart tells the story of restructuring and efforts to stabilize the business.
Share prices of companies in the market segment - Specialized medical equipment
Xtant Medical Holdings develops and markets a wide range of products for orthopedic and spinal surgery, including implants and biological materials. We classify it as "Specialized Medical Equipment." The chart below shows the dynamics of this sector.
Broad Market Index - GURU.Markets
Xtant Medical develops and markets biological and orthopedic implants for spinal surgery. As a significant player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Xtant's performance to assess the state of this sector.
Change in the price of a company, segment, and market as a whole per day
XTNT - Daily change in the company's share price XTNT
Xtant Medical Holdings' daily share price fluctuations reflect the volatility of the spinal implant sector. This metric measures the company's sensitivity to innovation, competition, and demographic trends, serving as a basis for analysis.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
Xtant Medical Holdings' daily share price fluctuations reflect the volatility of the spinal implant sector. This metric measures the company's sensitivity to innovation, competition, and demographic trends, serving as a basis for analysis.
Daily change in the price of a broad market stock, index - GURU.Markets
Xtant Medical produces implants and biomaterials for spinal surgery. This medtech company's stock performance depends on the number of surgeries performed and the adoption of its products in clinics. Its history reflects the innovative medical sector's contribution to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization XTNT
For Xtant Medical Holdings, year-over-year performance tells the story of its performance in the spine surgery market. Its market capitalization growth over the past 12 months reflects demand for its bone grafts and implants, as well as its success in integrating acquired companies and expanding its distribution network among orthopedic surgeons.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
Xtant Medical Holdings, Inc. is a company specializing in regenerative surgical products. This chart illustrates how its restructuring efforts, competition in the medical device sector, and reliance on elective surgeries are impacting its complex performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Xtant, a spinal implant manufacturer, is a growth story in the defense sector. Demand for its products is driven by demographics and medical needs. The company's stock performance reflects its success in innovation and acquisitions, making it a non-cyclical company.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization XTNT
Xtant Medical manufactures and markets biological implants for spinal surgery. Its monthly performance reflects demand for its products from hospitals and surgeons. Quarterly reports on sales growth and profitability are key indicators of its operational effectiveness.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
Xtant Medical Holdings, Inc. develops and commercializes orthobiologic drugs and implants for spinal surgery. The dynamics of its sector, shown in the graph, reflect innovation in medicine. Against this backdrop, one can appreciate how its product portfolio, including allografts and fixation systems, helps surgeons improve spinal surgery outcomes.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Xtant Medical produces implants for spinal surgery. The company's stock price is dependent on the number of elective surgeries, which can decline during periods of economic uncertainty. The chart shows how the stock reacts to the state of the healthcare system and consumer confidence, which influences elective treatment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization XTNT
Xtant Medical, a manufacturer of bone regeneration products for surgery, whose weekly stock price reflects demand for biomaterials in orthopedics and neurosurgery. The volume of elective surgeries and market competition shape short-term trends.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
Xtant Medical produces and sells biological implants for spinal surgery. Comparing its weekly performance with the medical equipment sector on this chart will demonstrate how competitive its products are and how they are affected by overall trends in healthcare and surgical technology.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Xtant Medical produces biological implants. The healthcare sector is considered defensive. The chart will help you assess whether XTNT shares behave like a defensive asset or, as a small company, are more volatile and follow overall market sentiment.
Market capitalization of the company, segment and market as a whole
XTNT - Market capitalization of the company XTNT
Xtant Medical's market capitalization is a financial barometer for spine surgery. The stock price of this company, which produces implants and biological materials for spine surgeries, reflects surgeon demand for its products. Its performance is an indicator of its ability to compete in the market and innovate in this complex medical field.
XTNT - Share of the company's market capitalization XTNT within the market segment - Specialized medical equipment
Xtant Medical's market share in the specialized medical equipment sector reflects its focus on biomaterials for spine surgery. Its market share is driven by demand for its bone regeneration products, which are used by surgeons in complex orthopedic procedures.
Market capitalization of the market segment - Specialized medical equipment
Xtant Medical manufactures and sells biological and orthopedic implants for spinal surgery. The chart below shows the overall market capitalization of the entire medical equipment sector. Its growth reflects an aging population and the constant advancement of surgical technologies.
Market capitalization of all companies included in a broad market index - GURU.Markets
Xtant Medical produces and sells biological implants and fixators for spinal surgery. Its market capitalization reflects its role in this competitive market. The chart below shows the economic weight of spinal surgery material manufacturers.
Book value capitalization of the company, segment and market as a whole
XTNT - Book value capitalization of the company XTNT
The book value of Xtant Medical, a manufacturer of spinal implants, is its production capacity and inventory. The chart below shows the underlying financial position of its business. Its dynamics can reflect both sales growth and the write-off of obsolete inventory.
XTNT - Share of the company's book capitalization XTNT within the market segment - Specialized medical equipment
Xtant Medical manufactures and supplies biological implants for spinal surgery. This requires laboratories and sterile manufacturing facilities. The asset share chart shows how the company is investing in creating a unique physical base for its products.
Market segment balance sheet capitalization - Specialized medical equipment
Xtant Medical is a manufacturer of spinal implants. Its strength lies in its manufacturing facilities, where biological tissue is processed and implants are created. This is a capital-intensive business. The chart illustrates how dependent the entire medical device industry is on investment in advanced manufacturing facilities.
Book value of all companies included in the broad market index - GURU.Markets
Xtant Medical's assets include manufacturing facilities for the creation of human tissue implants (allografts) for spinal and orthopedic surgery. Its book value reflects its ability to process and supply these complex biological products essential for patient recovery.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - XTNT
Xtant Medical produces and sells bone regeneration products used in spine surgery. Its balance sheet reflects its inventory and production assets. Its market capitalization depends on its ability to compete with larger players. The chart shows how the market values ββits niche products in the conservative medical industry.
Market to book capitalization ratio in a market segment - Specialized medical equipment
Xtant Medical manufactures and markets orthopedic implants, primarily for spinal surgery. The company combines manufacturing and development. The chart shows how the market evaluates its product portfolio and its position in the competitive medical device market.
Market to book capitalization ratio for the market as a whole
Xtant Medical manufactures and sells biological implants for spinal and orthopedic surgery. The chart shows how the market values ββthis specialized medical product provider. Its value is determined by its product portfolio, production capacity, and relationships with surgeons, which shape its market valuation relative to its tangible assets.
Debts of the company, segment and market as a whole
XTNT - Company debts XTNT
Xtant Medical develops and markets products for orthopedic and spinal surgery. The company's debt load may reflect its restructuring efforts, investments in new product development, and funding for working capital needed to support hospitals and surgeons, as this chart illustrates.
Market segment debts - Specialized medical equipment
Xtant Medical develops and markets biological and orthopedic implants for spinal surgery. This is a competitive medical device sector. This chart shows the financial norms for the industry, where companies must invest in research, clinical data, and marketing to convince surgeons to use their products to improve patient outcomes.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio XTNT
Xtant Medical Holdings develops and markets biological implants for spinal surgery. The medical device market is highly competitive. This chart shows how the company uses debt to finance the production, research, and commercialization of its products. This is an important indicator of its financial strategy and sustainability.
Market segment debt to market segment book capitalization - Specialized medical equipment
The production and sale of biological surgical implants, Xtant Medical's specialty, is a significant segment of the medical device market. This chart reflects the sector's debt burden. It allows one to assess how Xtant's financial strategy, focused on regenerative medicine, differs from that of manufacturers of synthetic or metal implants.
Debt to book value of all companies in the market
Xtant Medical Holdings develops and markets biological and orthopedic implants. Medical technologies require constant investment in research and regulatory approvals. The chart shows how their debt load, necessary for innovation, compares to market norms.
P/E of the company, segment and market as a whole
P/E - XTNT
This chart shows the valuation of Xtant Medical, a company that produces biological implants for spinal surgery. For a medical technology company, this metric reflects investor expectations regarding demand for its products and its ability to compete in the orthopedic market.
P/E of the market segment - Specialized medical equipment
This chart shows the average valuation for the medical implant sector, where Xtant Medical operates. This metric reflects how investors generally view the growth and innovation prospects in this industry. It helps understand whether Xtant's products are overvalued or undervalued by the market compared to competitors.
P/E of the market as a whole
Xtant Medical manufactures and supplies biological implants and fixators for spinal surgery. The company's growth depends on innovation in this field and relationships with surgeons. This chart shows the mood in the medical technology sector. It helps understand how demographic trends (aging population) and advances in surgical techniques influence demand for Xtant Medical products.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company XTNT
Xtant Medical manufactures and markets a wide range of biological and orthopedic implants for spinal surgery. The company's future growth depends on demand for its products from surgeons and hospitals. This chart reflects market expectations regarding the recovery of elective surgery volumes and the competitiveness of its spinal surgery product portfolio.
Future (projected) P/E of the market segment - Specialized medical equipment
Xtant Medical develops and markets products for orthopedic and spinal surgery, primarily biological implants (based on human tissue) and fixators. The chart shows sector expectations, helping to understand how the market views this niche player in the spinal surgery medical device industry.
Future (projected) P/E of the market as a whole
Xtant Medical develops and markets biological implants and fixators for spinal surgery. Their products help treat complex orthopedic conditions. This general expectations chart reflects the state of the healthcare system. Market optimism indicates hospitals' willingness to invest in advanced surgical materials to improve patient outcomes, which drives Xtant sales.
Profit of the company, segment and market as a whole
Company profit XTNT
Xtant Medical develops and markets biological and orthopedic implants for spinal surgery. This chart reflects the demand for spinal surgery products. The company's profit depends on sales of its implants, which are used by surgeons for spinal fusion and other procedures. Innovation and relationships with physicians are key to success.
Profit of companies in the market segment - Specialized medical equipment
Nixxy Inc., formerly Recruiter.com, operates a recruiting platform. Its profitability depends on the labor market and competition in the HR technology space. This chart illustrates how the digitalization of the recruiting process is creating new opportunities, but the cyclical nature of the economy and the constant need for innovation make maintaining profitability in this sector challenging.
Overall market profit
Xtant Medical develops and markets bone regeneration products used in spine and orthopedic surgery. Demand for the company's products is driven by the volume of surgical procedures and demographic factors such as an aging population. This makes its business less dependent on short-term economic cycles.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company XTNT
Xtant Medical manufactures and sells biological and orthopedic implants for spinal surgery, orthopedics, and traumatology. The company's profit forecast depends on the number of surgeries performed and demand for its products. This chart shows analyst expectations for the spinal surgery market and Xtant's ability to compete in it.
Future (predicted) profit of companies in the market segment - Specialized medical equipment
Xtant Medical develops and markets biological and orthopedic implants for spinal surgery. The company's products help surgeons restore spinal function in patients. This chart shows profitability forecasts for the medical device sector. It reflects the demand for innovative spinal surgery solutions driven by an aging population.
Future (predicted) profit of the market as a whole
Xtant Medical Holdings develops and markets products for orthopedic and spinal surgery. Demand for its products depends on the volume of surgeries performed, which can be sensitive to economic conditions (elective surgeries may be postponed). This revenue forecast chart helps assess the overall economic stability that influences patient and hospital decisions.
P/S of the company, segment and market as a whole
P/S - XTNT
Xtant Medical produces and markets biological implants and fixators for spine surgery, orthopedics, and traumatology. Its products are used to stimulate bone growth. The chart shows how investors view the company's sales in the competitive surgical medical device market, driven by an aging population.
P/S market segment - Specialized medical equipment
Xtant Medical Holdings, Inc. develops, manufactures, and markets orthopedic and spinal implants, as well as biological surgical materials. The company's products help treat various spinal conditions. This chart shows the average market value for Xtant Medical's product portfolio and market position.
P/S of the market as a whole
Xtant Medical Holdings develops and markets biological products and medical devices for orthopedic and spinal surgery. The company's products aid in bone tissue regeneration. This chart helps assess the market's revenue metrics for this niche manufacturer of medical materials essential for complex surgical procedures.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company XTNT
Xtant Medical develops and markets orthopedic implants and biomaterials for spinal surgery. This chart illustrates how investors estimate the company's future revenue. It reflects expectations for demand for spinal surgery products due to an aging population and the company's ability to compete in the medical device market.
Future (projected) P/S of the market segment - Specialized medical equipment
Xtant Medical Holdings develops and markets biological products for orthopedic and spinal surgery, such as bone grafts that promote tissue regeneration. The chart shows how the market estimates Xtant Medical's future sales, reflecting demand for its products in the fields of reconstructive medicine and spine surgery.
Future (projected) P/S of the market as a whole
Investor sentiment regarding future revenue depends on innovations in medical technology, particularly in surgery. Xtant Medical supplies biological implants and fixators for spinal surgeries. Demand for its products from surgeons and hospitals reflects the ongoing pursuit of improved treatment outcomes and patient recovery.
Sales of the company, segment and market as a whole
Company sales XTNT
Xtant Medical Holdings develops and markets biological products for orthopedic and spinal surgery. The company's revenue is generated by sales of regenerative materials, such as bone grafts, which surgeons use to restore bone. This graph illustrates the demand for innovative bone regeneration solutions.
Sales of companies in the market segment - Specialized medical equipment
Xtant Medical Holdings develops and supplies a wide range of biological and orthopedic implants for spine surgery, orthopedics, and traumatology. This chart shows total revenue in the specialized medical equipment sector. It reflects the stable demand for bone grafting implants, driven by an aging population and the number of surgical procedures.
Overall market sales
Xtant Medical manufactures and markets orthopedic implants and biomaterials used in spinal surgeries. The company's products help treat degenerative diseases and injuries. Demand depends on the number of surgical procedures performed. This overall healthcare situation impacts hospital budgets and their ability to perform elective surgeries.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company XTNT
Xtant Medical develops and markets biological and orthopedic implants for spinal surgery. Demand for its products depends on the number of procedures performed and the acceptance of its materials by surgeons. This chart reflects analyst revenue expectations, based on their forecasts for spinal surgery market growth and product competitiveness.
Future (projected) sales of companies in the market segment - Specialized medical equipment
Xtant Medical develops and markets biological and orthopedic implants for spinal surgery, orthopedics, and traumatology. The company's products aid in bone tissue restoration. This chart shows projected sales for the entire specialized medical equipment segment, reflecting overall expectations for the surgical and orthopedic implant market.
Future (projected) sales of the market as a whole
Xtant Medical develops and markets biological and orthopedic implants for spinal surgery. Demand for its products depends on the number of surgeries performed and hospital budgets. This general economic activity pattern impacts the healthcare system, specifically the number of elective surgeries and the ability of clinics to procure necessary supplies.
Marginality of the company, segment and market as a whole
Company marginality XTNT
Xtant Medical develops and markets biological and orthopedic implants for spinal surgery. This metric reflects the commercial effectiveness of its products. It shows what percentage of revenue from the sale of its specialized medical devices the company converts into net profit by managing production and distribution.
Market segment marginality - Specialized medical equipment
Xtant Medical Holdings develops and markets biological and orthopedic implants for spinal surgery. Profitability depends on innovation, relationships with surgeons, and manufacturing efficiency. This metric demonstrates the company's operating profitability compared to other manufacturers of specialized medical equipment.
Market marginality as a whole
Xtant Medical develops and markets biological and orthopedic implants for spinal surgery. Their products help treat complex spinal conditions. The company's growth depends on innovation and relationships with surgeons. This overall profitability curve impacts hospital budgets, which are more willing to purchase advanced medical devices in stable times.
Employees in the company, segment and market as a whole
Number of employees in the company XTNT
Xtant Medical Holdings develops and markets biological and orthopedic implants for spinal surgery. This chart shows the size of its commercial and manufacturing teams. The growth is driven by the expansion of its product portfolio, the expansion of its distributor network, and surgeon demand for innovative spinal solutions.
Share of the company's employees XTNT within the market segment - Specialized medical equipment
Xtant Medical Holdings develops and markets biological materials and implants for spinal surgery. This chart shows the percentage of orthopedic regenerative medicine specialists the company attracts. Its team creates products that help surgeons restore bone tissue.
Number of employees in the market segment - Specialized medical equipment
Xtant Medical Holdings, Inc. develops and markets biological and orthopedic implants for spine surgery, orthopedics, and traumatology. This chart shows overall employment in the specialized medical equipment sector. It illustrates the demand for innovative solutions for bone and soft tissue restoration, Xtant's core competencies.
Number of employees in the market as a whole
Xtant Medical develops and markets biological and orthopedic implants for spinal surgery, orthopedics, and traumatology. The company's products aid in bone tissue restoration. This chart illustrates the labor market, where the medical technology sector is creating jobs for biomedical engineers, sales specialists, and production personnel.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company XTNT (XTNT)
Xtant Medical Holdings, Inc. develops and markets biological and orthopedic implants for surgery. This chart shows how the market values ββthe company in the medical device sector. The moderately high market capitalization per employee reflects the balance between the value of patents and R&D and the need for manufacturing and a sales network to distribute products.
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Xtant Medical develops and markets products for orthopedic and spinal surgery, including biological implants. This sector is at the intersection of medicine and manufacturing. This metric reflects the value of their product portfolio and technologies. A high metric may indicate the presence of unique, patented products that generate high margins and market valuation.
Market capitalization per employee (in thousands of dollars) for the overall market
Xtant Medical Holdings develops and markets biological implants for spinal surgery. It is a medical technology company. Its employee rating reflects the value of its products, which are used by surgeons to restore bone tissue, as well as the effectiveness of its sales team in working with hospitals and physicians.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company XTNT (XTNT)
Xtant Medical supplies products for spinal surgery. Their portfolio includes both biological implants (processed human tissue) and metal implants (screws and plates). It's a hybrid med-tech business. This chart shows how much net profit each employee, from lab technician to salesperson, generates.
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Xtant Medical supplies biological implants and instruments for spinal surgery. This schedule is a benchmark in the medical technology sector. XTNT's success depends on the productivity of its sales team and the profitability of its specialized products. They must constantly prove the value of their solutions to surgeons to stay ahead of the competition.
Profit per employee (in thousands of dollars) for the market as a whole
Xtant Medical (XTNT) develops and supplies biological implants (based on donor tissue) and spinal fixators. It's a complex medical business. This metric reflects their operational efficiency: from processing donor tissue to implant manufacturing and sales to surgeons.
Sales to employees of the company, segment and market as a whole
Sales per company employee XTNT (XTNT)
For Xtant Medical, a manufacturer of bio-based orthopedic implants, this chart demonstrates the commercial success of its products. The growth in revenue per employee reflects surgeon demand for its bone and tissue repair solutions during complex surgeries.
Sales per employee in the market segment - Specialized medical equipment
Xtant Medical manufactures and supplies biological implants and fixators for spinal surgery. It is a niche medical technology company. This metric measures average revenue per employee by segment. It helps assess how productive Xtant's team is in producing and selling its specialized surgical materials compared to competitors.
Sales per employee for the market as a whole
Xtant Medical (XTNT) develops and markets biological and orthopedic implants for spinal surgery. This metric reflects the commercial effectiveness of their dedicated sales team. The growth in revenue per employee demonstrates that their product portfolio (such as bone grafts) is in demand by surgeons, and the company is successfully competing in this market.
Short shares by company, segment and market as a whole
Shares shorted by company XTNT (XTNT)
Xtant Medical Holdings supplies biological implants and fixators for spinal surgery. It's a highly competitive market dominated by large players. This chart reflects investor bets that Xtant, as a small player, will be unable to compete on price and innovation and will lose market share to industry giants.
Shares shorted by market segment - Specialized medical equipment
Xtant Medical (XTNT) supplies biological and orthopedic implants, primarily for spine surgery. This chart shows the overall short position in the spine medical equipment sector. It reflects investor doubts about the growth of this competitive market or concerns about pricing pressure from hospitals.
Shares shorted by the overall market
Xtant Medical specializes in implants for spinal surgery. Many of these surgeries are elective. When this fear indicator rises, investors anticipate a recession. During such periods, patients postpone "non-urgent" but expensive surgeries, which directly impacts demand for XTNT products.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator XTNT (XTNT)
This oscillator for Xtant Medical shows the market's reaction to surgical innovations. The company supplies complex implants and biomaterials for spinal surgery. When Xtant reports sales growth for its key products or receives FDA approval for a new implant, investors overheat the stock (above 70). Pricing pressure from competitors or product launch delays lead to oversold prices.
RSI 14 Market Segment - Specialized medical equipment
Xtant Medical (XTNT) is a back "parts" company. They don't make hardware, but supply biological (bone grafts) and orthopedic implants for spinal surgery. The "Specialized medical equipment" (medtech) sector thrives on R&D. RSI_14_Seg shows whether the entire sector is overbought. This helps differentiate: is XTNT's growth a niche or a general overheating?
RSI 14 for the overall market
Xtant Medical (XTNT) produces implants for spinal surgery. This chart is an indicator of elective surgeries. During periods of euphoria and stability, patients confidently undergo expensive elective surgeries. During periods of market panic and rising unemployment, people, fearing loss of insurance, postpone "non-urgent" surgeries.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast XTNT (XTNT)
Xtant Medical specializes in "biological" implants for spinal surgery. It produces allografts (donor bone) and other products for spinal surgeons. This chart shows the average target price from analysts estimating growth in demand for these materials.
The difference between the consensus estimate and the actual stock price XTNT (XTNT)
XTNT - Xtant Medical is a regenerative medicine company that produces and supplies biological implants (grafts) for spinal and orthopedic surgery. This chart shows how the current share price differs from the "fair" value predicted by analysts. It reflects their belief in the spinal surgery market.
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
Xtant Medical (XTNT) is a company specializing in "biological" implants for spinal surgery. It supplies bone grafts (allografts) for spinal surgeries. This chart shows general expectations for the specialized medical equipment sector. It reflects whether experts believe the biological materials market will grow.
Analysts' consensus forecast for the overall market share price
Xtant Medical produces "biological" implants for spinal surgery. They also supply bone grafts (allografts) and fixators. This chart shows overall market sentiment. For Xtant, which operates in the defensive healthcare sector (spine surgeries), overall optimism is important, but their growth is more dependent on elective surgeries and demographics.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index XTNT
Xtant (XTNT) is a single-product company. Their specialty is biological implants (allografts) for spinal surgery. They take donor tissue and transform it into implants. This chart is an indicator of their turnaround. It reflects their (difficult) struggle for profitability in this competitive market and their reliance on surgeons who prefer biological implants over titanium.
AKIMA Market Segment Index - Specialized medical equipment
Xtant Medical specializes in biological implants for spinal surgery. It also supplies bone grafts and fixators. This chart shows the average index for the specialized medical equipment sector. It helps assess how far Xtant Medical is ahead of or behind the industry average.
The AKIM Index for the overall market
Xtant Medical is a manufacturer of orthobiological materials and fixation systems for spinal surgery. This chart, reflecting the market average, is a backdrop. It helps assess how this micro-cap MedTech player, recovering from difficulties, compares to overall macroeconomic trends in healthcare.